Filter
358
Text search:
Food
and
Drug
Administration
(FDA)
Featured
Recommendations
38
New Publications
80
Language
Document type
No document type
192
Guidelines
81
Studies & Reports
47
Manuals
13
Fact sheets
9
Strategic & Response Plan
8
Training Material
2
Situation Updates
2
Resource Platforms
2
Brochures
1
Infographics
1
Countries / Regions
Ghana
14
India
14
Myanmar / Burma
11
Philippines
9
Russia
7
Global
7
Nigeria
6
USA
6
South Africa
6
Latin America and the Carribbean
6
Uganda
5
Western and Central Europe
5
Congo, Democratic Republic of
4
South Sudan
4
Ethiopia
3
Nepal
3
Germany
3
Kenya
3
Thailand
3
Indonesia
3
Syria
2
Tanzania
2
Rwanda
2
Bangladesh
2
Sudan
2
Namibia
2
Peru
2
Brazil
2
Colombia
2
Angola
2
West and Central Africa
2
Middle East and North Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Paraguay
2
Africa
2
Sierra Leone
1
Liberia
1
Senegal
1
Guinea-Bissau
1
Zimbabwe
1
Haiti
1
Iraq
1
Jordan
1
Cambodia
1
Singapore
1
Malawi
1
Mozambique
1
Argentina
1
Botswana
1
Yemen
1
Asia
1
Venezuela
1
Eastern Europe
1
Authors & Publishers
Publication Years
Category
Countries
102
Clinical Guidelines
60
Pharmacy & Technologies
16
Women & Child Health
10
Public Health
9
Key Resources
3
Capacity Building
2
Toolboxes
COVID-19
51
Mental Health
37
HIV
35
TB
34
AMR
21
Pharmacy
18
Ebola & Marburg
12
Specific Hazards
9
NTDs
9
NCDs
8
Rapid Response
7
Malaria
7
Planetary Health
5
Refugee
4
Cholera
3
Zika
3
Conflict
2
Global Health Education
2
Disability
1
Caregiver
1
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spr
...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules)
...
Therapeutics Information and Pharmacovigilance Centre | TIPC
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering
...
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
Cloth masks and mask sterilisation as options in case of shortage of surgical masks and respirators
recommended
This document aims to provide advice on the use of cloth face masks and sterilisation of respirators and surgical masks as an alternative in healthcare settings with suspected or confirmed COVID-19
...
N95 or equivalent respirators are single-use personal protective equipment (PPE) designed for use by health workers that provide direct care to patients with diseases transmitted by aerosols or during aerosol generating procedures (AGP) for patients with acute respiratory disease, as is the case of
...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has impr
...
